Cholangiocarcinoma: what are the most valuable therapeutic targets–cancer-associated fibroblasts, immune cells, or beyond T cells?

Juan Wang, Emilien Loeuillard, Gregory J. Gores, Sumera I. Ilyas

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cholangiocarcinoma: what are the most valuable therapeutic targets–cancer-associated fibroblasts, immune cells, or beyond T cells?'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences